Hepatitis C disease transmission and treatment uptake : impact on the cost-effectiveness of new direct-acting antiviral therapies
Year of publication: |
November 2017
|
---|---|
Authors: | Bennett, Hayley ; Gordon, Jason ; Jones, Beverley ; Ward, Thomas ; Webster, Samantha ; Kalsekar, Anupama ; Yuan, Yong ; Brenner, Michael ; McEwan, Phil |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 18.2017, 8, p. 1001-1011
|
Subject: | Hepatitis C virus | Disease transmission | Cost-effectiveness | PWID | Infektionskrankheit | Infectious disease | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | Gesundheitsvorsorge | Preventive care | Krankheit | Disease |
-
Grau, Santiago, (2018)
-
Cost-effectiveness and estimated health benefits of treating patients with vitamin D in pre-dialysis
Snyder, Sophie, (2020)
-
The costs of COVID-19 and the cost-effectiveness of testing
González López-Valcárcel, Beatriz, (2021)
- More ...
-
McEwan, Phil, (2013)
-
McEwan, Phil, (2010)
-
Leaving the ‘old broken model’ behind?
Clegg, Daniel, (2021)
- More ...